Philip Connor Selected Research

Philip Connor Research Topics

4	Hemorrhage 01/2022 - 08/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 12/2020
2	Thrombosis (Thrombus) 01/2022 - 01/2018
2	Venous Thromboembolism 01/2020 - 01/2020
2	Sideroblastic Anemia 10/2014 - 07/2013
1	Infections 01/2022
1	Headache (Headaches) 08/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2015
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2015
1	Anemia 07/2013
1	Aplastic Anemia (Anemia, Hypoplastic) 05/2012
1	Evans Syndrome 03/2008
1	Pulmonary Hypertension 03/2008

4	RivaroxabanIBA 01/2022 - 01/2020
3	AnticoagulantsIBA 01/2022 - 01/2020
2	Vitamin K FDA Link 01/2022 - 01/2020
2	IronIBA 10/2014 - 07/2013
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	TabletsIBA 01/2020
1	SuspensionsIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Thrombopoietin ReceptorsIBA 08/2015
1	eltrombopag FDA Link 08/2015
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2014
1	SulfurIBA 10/2014
1	Heme (Haem)IBA 10/2014
1	Proteins (Proteins, Gene)FDA Link 10/2014
1	Hemoglobins (Hemoglobin)IBA 07/2013
1	Sildenafil Citrate (Viagra)FDA Link 03/2008